Quarter 2027/Q2
| Line item | 2027 Q2 | 2027 Q1 | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Free Cash Flow | $99.58M | $13.28M | $54.68M | $82.89M | $80.42M |
| -Change in Other Current Assets | -$39.80M | -$38.56M | -$24.34M | -$18.21M | -$28.69M |
| -Change in Other Current Liabilities | -$38.19M | -$43.01M | -$55.66M | -$39.22M | -$6.72M |
| -Change In Other Working Capital | $19.99M | $44.07M | -$10.90M | -$2.49M | $1.26M |
| Net cash flow from investing | -$3.69M | -$39.22M | -$41.63M | -$47.91M | -$89.11M |
| Net Cash Flow from Continuing Investing Activities | -$3.69M | -$39.22M | -$41.63M | -$47.91M | -$89.11M |
| Capital Expenditure | -$45.64M | -$39.22M | -$41.46M | -$48.82M | -$57.00M |
| Net Intangibles Purchase and Sale | $0.00 | $0.00 | $69,000.00 | -$140,000.00 | -$262,000.00 |
| Financing Cash Flow | -$69.56M | -$584,000.00 | -$56.75M | -$75.41M | -$60.24M |
| Net Cash Flow from Continuing Financing Activities | -$69.56M | -$584,000.00 | -$56.75M | -$75.41M | -$60.24M |
| Net Issuance Payments Of Debt | -$70.92M | -$3.22M | -$56.24M | -$76.09M | -$57.99M |
| Proceeds from Stock Option Exercised | $1.27M | $2.74M | $2.19M | $943,000.00 | $428,000.00 |
| Net Other Financing Charges | $85,000.00 | -$103,000.00 | -$2.70M | -$255,000.00 | -$2.68M |
| Ending Cash Balance | $125.49M | $53.80M | $41.19M | $43.09M | $34.56M |
| Net Change in Cash | $71.97M | $12.70M | -$2.32M | $8.54M | -$11.67M |
| Effect of Exchange Rate Changes | -$276,000.00 | -$85,000.00 | $425,000.00 | -$13,000.00 | $141,000.00 |
| -Change in Payables and Accrued Expense | $22.79M | $16.58M | $16.52M | -$7.83M | -$11.94M |
| -Change in Prepaid Assets | $431,000.00 | -$11.40M | -$32.35M | -$8.39M | -$14.39M |
| -Change in Inventory | $28.42M | $15.37M | $58.53M | $81.66M | $55.59M |
| Net Income from Continuing Operations | $60.17M | -$13.70M | $28.78M | $36.27M | $51.71M |
| Beginning Cash Balance | $53.80M | $41.19M | $43.09M | $34.56M | $46.08M |
| Operating Cash Flow | $145.22M | $52.50M | $96.07M | $131.86M | $137.68M |
| Net cash flow from continuing operations | $145.22M | $52.50M | $96.07M | $131.86M | $137.68M |
| Depreciation & Depletion & Amortization | $40.93M | $38.75M | $40.26M | $38.38M | $34.63M |
| Gain/Loss from Continuing Operations | -$17.98M | $442,000.00 | $1.65M | $194,000.00 | $1.35M |
| Other Non-Cash Items | $43.44M | $41.04M | $40.89M | $40.17M | $36.70M |
| Change in Working Capital | -$13.10M | -$25.95M | -$48.46M | $3.61M | -$2.29M |
| -Change in Receivables | -$6.74M | -$8.99M | -$247,000.00 | -$1.91M | $2.60M |
| Net Investment Purchase and Sale | – | $0.00 | – | – | – |
| Net Business Purchase and Sale | – | – | -$374,000.00 | $374,000.00 | – |
| Net Other Investing Changes | – | – | -$246,000.00 | $1.05M | $275,000.00 |
| Net Common Stock Issuance | – | – | $0.00 | – | – |
| Deferred Tax | – | – | $25.63M | – | – |
No comments yet — be the first to weigh in on RH.